The Future Of OTCs: Self-Selection Meets Diagnostics, Genetic Personalization
The next generation of consumer health products, including Rx-to-OTC switch opportunities, may work in concert with cutting-edge diagnostic tools and elements of personalized medicine, says Andrew Fish.
More from Archive
More from Pink Sheet
• By
Kwabena Frimpong-Manso Opuni has been appointed as the new acting CEO of the Ghana Food and Drugs Authority, succeeding Delese Darko, who is now head of the Africa’s pan-continental medicines agency.
• By
The Health Research Authority is working on a streamlined model for informed consent that maintains people’s trust.
• By
The European Commission has published two new strategies on stockpiling that will improve the availability of critical medicines in times of crisis and reduce the EU’s dependance on suppliers outside the bloc.